Critically, both tumor types harbored the identical missense mutation c.131G > A (p.Gly44Asp) in exon 2, a known hotspot that disrupts MED12-Cyclin C binding and impairs CDK8/19 kinase activity within the Mediator transcriptional complex (Figure 1B). Here, MED12 is linked to neoplasm.